Table 3 Characteristics of studies evaluating Prolaris®
From: Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
First author and year | Number of cases | Study population | End point | Main results |
|---|---|---|---|---|
Cuzick et al. [32] 2011 | 703 patients | Transurethral resection of prostate or radical prostatectomy | Biochemical recurrence and disease free survival | Predict biochemical recurrence and disease free survival |
Cuzick et al. [33] 2012 | 349 patients | Prostate biopsies | Disease free survival | Predict disease free survival |
Cooperberg et al. [36] 2013 | 413 patients | Radical prostatectomy | Biochemical recurrence | Predict biochemical recurrence |
Freedland et al. [35] 2013 | 141 patients | Prostate biopsies in patients treated with EBRT | Biochemical recurrence and disease free survival | Predict disease free survival |
Bishoff et al. [34] 2014 | 582 patients | Prostate biopsies | Biochemical recurrence and metastases | Predict biochemical recurrence and metastases |